Datatrak International, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2019
March 24, 2020 at 01:18 pm EDT
Share
DATATRAK International, Inc. announced earnings results for the fourth quarter ended December 31, 2019. For the fourth quarter, the company announced sales was USD 1.908 million compared to USD 1.914 million a year ago. Operating income was USD 102,208 compared to USD 21,292 a year ago. Net income was USD 108,130 compared to USD 19,658 a year ago. Basic earnings per share was USD 0.05 compared to USD 0.01 a year ago. For the full year, sales was USD 7.742 million compared to USD 7.447 million a year ago. Operating income was USD 373,908 compared to USD 160,725 a year ago. Net income was USD 386,799 compared to USD 161,575 a year ago. Basic earnings per share was USD 0.16 compared to USD 0.07 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
